In a report published Thursday, Bank of America analyst Scott D. Craig downgraded the rating on Emulex (NYSE: ELX) from Buy to Underperform ... have a hard time finding reasons to buy/own the stock, at least near-term.” Emulex closed …
Arena Pharmaceuticals (ARNA): The pharmaceutical stock is now Hold from Buy at Hapoalim Securities. Emulex (ELX): ELX is downgraded to Hold from Buy at Jefferies. Buckeye Partners (BPL): BPL gets lowered to Hold from Buy with …
ELX-02 is in the early stages of clinical development focusing ... and the quotation of the Company’s common stock on …
The Director now holds 6,406,246 shares. Shares is the leading weekly publication for high net worth private investors and stock market professionals and as such is read weekly by thousands of private investors, analysts, fund managers, …
Emulex Corporation (ELX) is a Computer Networks cimpany that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings …
ELX-02 is in the early stages of clinical development focusing ... and the quotation of the Company’s common stock on …
KTVN12d
StockCall has posted free technicalresearch on NTAP, BRCD, FIO, QTM, and ELX which can be downloaded upon sign up at www.stockcall.com/signup NetApp Inc.’s stock is up 8.35 percent on a YTD basis thanks to a 0.20 percent gain …
ELX-02 is a fifth-generation designer aminoglycoside optimized ... and the quotation of the Company's common stock
Apr 28, 2010--AuthenTec (NASDAQ: AUTH), a leading provider of security ... Emulex is listed on the New York Stock Exchange (NYSE: ELX) and has corporate headquarters in Costa Mesa, California. News releases and other …